Choosing The Right FSP: 4 Key Considerations To Fuel More Efficient Drug Development

As the landscape of drug development continues to evolve, there is a shift in the trends of outsourcing models to accommodate new demands, priorities, and challenges. The strategic choice of the appropriate outsourcing model can enable developers to optimize quality, financial efficiency, operational effectiveness, and overall project success.

While the outsourcing process can vary significantly based on various factors, biotech and biopharmaceutical companies typically rely on two primary models: functional service provider (FSP) partnerships and full-service outsourcing (FSO). Some organizations also employ hybrid variations that combine elements of both models. FSO entails the outsourcing of complete clinical development services on a trial-by-trial basis, whereas FSP involves outsourcing specific functions, such as data management or monitoring, to external partners, either in part or in full.

Learn more about the benefits of using an FSP model and what four things to consider before choosing a partner.